Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.74T
Total marketcap
$47.15B
Total volume
BTC 59.88%     ETH 7.86%
Dominance

IN8bio INAB Stock

0.15 USD {{ price }} -6.265513% {{change_pct}}%
Exchange
NasdaqCM
Market Cap
12.28M USD
LOW - HIGH [24H]
0.14 - 0.16 USD
VOLUME [24H]
1.4M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.57 USD

IN8bio Price Chart

IN8bio INAB Financial and Trading Overview

IN8bio stock price 0.15 USD
Previous Close 0.3 USD
Open 0.29 USD
Bid 0.29 USD x 100
Ask 0.3 USD x 100
Day's Range 0.28 - 0.33 USD
52 Week Range 0.22 - 1.74 USD
Volume 395.7K USD
Avg. Volume 1.41M USD
Market Cap 21.5M USD
Beta (5Y Monthly) -0.069
PE Ratio (TTM) N/A
EPS (TTM) -0.57 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 4.75 USD

INAB Valuation Measures

Enterprise Value 12.05M USD
Trailing P/E N/A
Forward P/E -0.98866665
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.5149306
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.393

Trading Information

IN8bio Stock Price History

Beta (5Y Monthly) -0.069
52-Week Change -77.83%
S&P500 52-Week Change 22.67%
52 Week High 1.74 USD
52 Week Low 0.22 USD
50-Day Moving Average 0.31 USD
200-Day Moving Average 0.63 USD

INAB Share Statistics

Avg. Volume (3 month) 1.41M USD
Avg. Daily Volume (10-Days) 1.09M USD
Shares Outstanding 72.48M
Float 25.92M
Short Ratio 0.51
% Held by Insiders 21.55%
% Held by Institutions 46.45%
Shares Short 1M
Short % of Float 1.83%
Short % of Shares Outstanding 1.37%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2023
Most Recent Quarter (mrq) June 30, 2024
Next Fiscal Year End December 31, 2024

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -77.63%
Return on Equity (ttm) -180.45%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -30632000 USD
Net Income Avi to Common (ttm) -31958000 USD
Diluted EPS (ttm) -0.74
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 10.22M USD
Total Cash Per Share (mrq) 0.22 USD
Total Debt (mrq) 5.9M USD
Total Debt/Equity (mrq) 43.3 USD
Current Ratio (mrq) 2.665
Book Value Per Share (mrq) 0.576

Cash Flow Statement

Operating Cash Flow (ttm) -24573000 USD
Levered Free Cash Flow (ttm) -12407375 USD

Profile of IN8bio

Country United States
State NY
City New York
Address 350 5th Avenue
ZIP 10118
Phone 646 600 6438
Website https://in8bio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 39

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of solid and liquid tumors. Its lead product candidates include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM and other cancers; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company develops INB-300 and INB-500 that are in preclinical phase for treatment of acute myeloid leukemia, and other solid and hematological tumor types. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.

Q&A For IN8bio Stock

What is a current INAB stock price?

IN8bio INAB stock price today per share is 0.15 USD.

How to purchase IN8bio stock?

You can buy INAB shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for IN8bio?

The stock symbol or ticker of IN8bio is INAB.

Which industry does the IN8bio company belong to?

The IN8bio industry is Biotechnology.

How many shares does IN8bio have in circulation?

The max supply of IN8bio shares is 81.26M.

What is IN8bio Price to Earnings Ratio (PE Ratio)?

IN8bio PE Ratio is now.

What was IN8bio earnings per share over the trailing 12 months (TTM)?

IN8bio EPS is -0.57 USD over the trailing 12 months.

Which sector does the IN8bio company belong to?

The IN8bio sector is Healthcare.

IN8bio INAB included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 15587.79 USD
-5.82
9.14B USD 15575.68 USD 16128.16 USD 9.14B USD
NASDAQ Global Market Composite NQGM 1647.83 USD
-5.17
1610.28 USD 1681.06 USD
NASDAQ HealthCare IXHC 869.8 USD
-5.51
868.74 USD 900.72 USD